Study finds no link between vancomycin, hemorrhagic occlusive retinal vasculitis

CHICAGO — An analysis of a large series of cataract surgeries found no association between hemorrhagic occlusive retinal vasculitis and the use of vancomycin in the infusion solution.
“Our review of a large series of cases suggests that 0.02 mg/mL of vancomycin is safe for use as endophthalmitis prophylaxis,” Robert DeBurlo said at the American Academy of Ophthalmology meeting. “This is consistent with our view of the literature indicating only mild cases of HORV with vancomycin in the infusion solution and a dose-dependent response to vancomycin.”
DeBurlo and

CHICAGO — An analysis of a large series of cataract surgeries found no association between hemorrhagic occlusive retinal vasculitis and the use of vancomycin in the infusion solution.
“Our review of a large series of cases suggests that 0.02 mg/mL of vancomycin is safe for use as endophthalmitis prophylaxis,” Robert DeBurlo said at the American Academy of Ophthalmology meeting. “This is consistent with our view of the literature indicating only mild cases of HORV with vancomycin in the infusion solution and a dose-dependent response to vancomycin.”
DeBurlo and